| 臺大學術典藏 |
2021-01-04T12:12:58Z |
Clinical significance of cytogenetics and interphase fluorescence in situ hybridization analysis in newly diagnosed multiple myeloma in Taiwan
|
Liu M.-C.; Wang C.-H.; Lee F.-Y.; Tsay W.; Yao M.; Tang J.-L.; Huang S.-Y.; Chen Y.-C.; Shen M.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:57Z |
Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome [1]
|
HWEI-FANG TIEN; Lin K.-H.; Lin D.-T.; Chen Y.-C.; Ko B.-S.; Yao M.; Chiou R.-J.; Huang C.-F.; Yeh Y.-C.; Chang H.-H.; Tsay W.; Lin L.-I.; Tang J.-L.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:55Z |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
Huang S.-Y.; Chen C.-Y.; Ko B.-S.; Chou W.-C.; Tang J.-L.; Yao M.; Wu S.-J.; Tsay W.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Yeh Y.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:55Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
HWEI-FANG TIEN; Huang C.-F.; Chen C.-Y.; Huang S.-Y.; Huang K.-C.; Yao M.; Tsay W.; Wu S.-J.; Tang J.-L.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:53Z |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Chen Y.-C.; Yao M.; Huang S.-Y.; Tsay W.; Chen C.-Y.; Tang J.-L.; Hsu C.; Huang T.-C.; Ko B.-S.; HWEI-FANG TIEN; Shen M.-C.; Wang C.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:51Z |
HLA-DR-matched parental donors for allogeneic hematopoietic stem cell transplantation in patients with high-risk acute leukemia
|
Chen Y.-C.; HWEI-FANG TIEN; Tang J.-L.; Ko B.-S.; Yao M.; Wu S.-J. |
| 臺大學術典藏 |
2021-01-04T12:12:51Z |
Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute
|
Chen Y.-K.; Tang J.-L.; Yao M.; Hou H.-A.; Ko B.-S.; Huang S.-Y.; HWEI-FANG TIEN; Chang H.-H.; Lu M.-Y.; Lin T.-T.; Lin K.-H.; Hsiao C.-H.; Lin C.-W.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:46Z |
Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia
|
Tang J.-L.; Chen B.-B.; Liu C.-Y.; Shih T.T.F.; Hou H.-A.; Yao M.; Huang S.-Y.; Chou W.-C.; Hsu C.-Y.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:45Z |
Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever
|
Lin C.-A.; Lin M.-T.; Hsu S.-C.; Ho C.-C.; Yao M.; Lin C.-H.; Hu F.-C.; Yu C.-J.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:44Z |
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
|
Chen C.-Y.; Lin C.-W.; Jhuang J.-Y.; Cheng C.-L.; Hou H.-A.; Tang J.-L.; Chou W.-C.; Tseng M.-H.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:43Z |
Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia
|
Hou H.-A.; Kuo Y.-Y.; Liu C.-Y.; Lee M.C.; Tang J.-L.; Chen C.-Y.; Chou W.-C.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:42Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Hou H.-A.; Li Y.; Kuo Y.-Y.; Wu S.-J.; HWEI-FANG TIEN; Tsay W.; Tang J.-L.; Ko B.-S.; Yao M.; Huang S.-Y.; Chou W.-C.; Chen C.-Y.; Lin C.-T.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Huang C.-F.; Lee F.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:41Z |
Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis
|
Chen C.-Y.; Chou W.-C.; Tsay W.; Tang J.-L.; Yao M.; Huang S.-Y.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:39Z |
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
|
Wu S.-J.; HWEI-FANG TIEN; Tsay W.; Ko B.-S.; Huang S.-Y.; Yao M.; Tang J.-L.; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Hou H.-A.; Chen C.-Y.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:35Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Chou W.-C.; Lin C.-C.; Hou H.-A.; HWEI-FANG TIEN; Chen Y.-C.; Tsay W.; Wu S.-J.; Kuo Y.-Y.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S. |
| 臺大學術典藏 |
2021-01-04T12:12:34Z |
Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12
|
HWEI-FANG TIEN; Tsay W.; Tang J.-L.; Chou W.-C.; Yao M.; Huang S.-Y.; Chen C.-Y.; Sheng W.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-04T12:12:33Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
HWEI-FANG TIEN; Tsay W.; Chen Y.-C.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Chen Y.-K.; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:32Z |
High risk of hepatitis B reactivation among patients with acute myeloid leukemia
|
HWEI-FANG TIEN; Tsay W.; Sheng W.-H.; Tang J.-L.; Yao M.; Chou W.-C.; Cheng A.; Huang S.-Y.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:31Z |
Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study
|
Lin H.-H.; Huang S.-Y.; Tsay W.; Lu H.-Y.; Ko B.-S.; Hsu S.-C.; Chou W.-C.; Chou S.-C.; Hou H.-A.; Wu S.-J.; Yao M.; Tang J.-L.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:30Z |
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
|
Kuo Y.-Y.; Hou H.-A.; Liu C.-Y.; Huang S.Y.; Li C.-C.; Yao M.; Liu C.-W.; Tang J.-L.; Chiang Y.-C.; Liu M.-C.; Tseng M.-H.; Lin L.-I.; Lin C.-C.; Tsai C.-H.; Chou W.-C.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:28Z |
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
|
Tang J.-L.; Liu C.-Y.; Hou H.-A.; Tsai C.-H.; HWEI-FANG TIEN; Wu S.-J.; Lin C.-T.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:23Z |
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
|
Lin M.-E.; Ko B.-S.; Huang S.-Y.; Li C.-C.; Tang J.-L.; Yao M.; Chen C.-Y.; Chou W.-C.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Kuo Y.-Y.; Wu S.-J.; Hou H.-A.; Tsai C.-H.; Hsu S.-C.; Lin C.-T.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:22Z |
2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan
|
Vaccines; Education, CY Lee's Research Foundation for Pediatric Infectious Diseases; Marrow Transplantation, Medical Foundation in Memory of Dr Deh-Lin Cheng, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research; Ko B.-S.; Chen W.-T.; Kung H.-C.; Wu U.-I.; Tang J.-L.; Yao M.; Chen Y.-C.; HWEI-FANG TIEN; Chang S.-C.; Chuang Y.-C.; Lin D.-T.; The Infectious Diseases Society of Taiwan, The Hematology Society of Taiwan, The Taiwan Society of Blood |
| 臺大學術典藏 |
2021-01-04T12:12:21Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Tien F.-M.; HWEI-FANG TIEN; Chou W.-C.; Yao M.; Huang S.-Y.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:20Z |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Tang J.-L.; HWEI-FANG TIEN; Li C.-C.; Hsu C.-A.; Ko B.-S.; Yao M.; Wu S.-J.; Lin C.-T.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-04T12:12:20Z |
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
|
Wu S.-J.; Tsai C.-H.; Huang T.-C.; Lin C.-T.; Liu J.-H.; Yao M.; Huang H.-H.; Hou H.-A.; Hsu S.-C.; Weng P.-F.; Li C.-C.; Li J.-L.; Ko B.-S.; Wang Y.-F.; Huang S.-Y.; Chou W.-C.; HWEI-FANG TIEN; Lee C.-C.; Tang J.-L. |
| 臺大學術典藏 |
2021-01-04T12:12:19Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Chiu Y.-C.; Kuo Y.-Y.; Tien F.-M.; Tang J.-L.; Yao C.-Y.; Tsai C.-H.; HWEI-FANG TIEN; Hou H.-A.; Chen C.-Y.; Lin L.-I.; Chou W.-C.; Yao M.; Liu C.-W.; Liu M.-C.; Peng Y.-L.; Lin C.-C.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:18Z |
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
|
Tseng M.-H.; HWEI-FANG TIEN; Huang S.-Y.; Chen C.-Y.; Hsu S.-C.; Wu S.-J.; Tsay W.; Yao M.; Li C.-C.; Tang J.-L.; Lin C.-T.; Ko B.-S.; Chou W.-C.; Hou H.-A.; Huang H.-H.; Chen F.-Y.; Chen R.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:16Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Lin C.-C.; Wang Y.-W.; Tsai C.-H.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:14Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Yao M.; Kuo Y.-Y.; Hou H.-A.; Huang T.-C.; Wu S.-J.; Tsai C.-H.; Wang Y.-H.; Lin C.-C.; Lee S.-H.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; HWEI-FANG TIEN |
| 國立成功大學 |
2021 |
Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome
|
Chien, S.-H.;Yao, M.;Li, C.-C.;Chang, P.-Y.;Yu, M.-S.;Huang, C.-E.;Tan, Tan T.-D.;Lin, C.-H.;Yeh, S.-P.;Li, S.-S.;Wang, P.-N.;Liu, Y.-C.;Gau, J.-P. |
| 國立成功大學 |
2021 |
Validation of a Post-Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database
|
Lee, C.-C.;Hsu, T.-C.;Kuo, C.-C.;Liu, M.A.;Abdelfattah, Abdelfattah A.M.;Chang, Chang C.-N.;Yao, M.;Li, C.-C.;Wu, K.-H.;Chen, T.-C.;Gau, J.-P.;Wang, P.-N.;Liu, Y.-C.;Chiou, L.-W.;Lee, M.-Y.;Li, S.-S.;Chao, T.-Y.;Jou, S.-T.;Chang, H.-H. |
| 臺大學術典藏 |
2020-12-30T02:45:54Z |
High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in Taiwan
|
Tang J.-L.;Kung H.-C.;Lei W.-C.;Yao M.;Wu U.-I.;Hsu S.-C.;Lin C.-T.;Li C.-C.;Wu S.-J.;Hou H.-A.;Chou W.-C.;Huang S.-Y.;Tsay W.;Chen Y.-C.;Chen Y.-C.;Shan-Chwen Chang;Ko B.-S.;Tien H.-F.; Tang J.-L.; Kung H.-C.; Lei W.-C.; Yao M.; Wu U.-I.; Hsu S.-C.; Lin C.-T.; Li C.-C.; Wu S.-J.; Hou H.-A.; Chou W.-C.; Huang S.-Y.; Tsay W.; Chen Y.-C.; Chen Y.-C.; SHAN-CHWEN CHANG; Ko B.-S.; Tien H.-F. |
| 臺大學術典藏 |
2020-12-30T02:45:33Z |
Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy
|
Tang J.-L.; Chen C.-Y.; Chen C.-Y.;Tang J.-L.;Hsueh P.-R.;Yao M.;Huang S.-Y.;Chen Y.-C.;Chen Y.-C.;Shen M.-C.;Wang C.-H.;Tsai W.;Shan-Chwen Chang;Tien H.-F.;Luh K.-T.; Hsueh P.-R.; Yao M.; Huang S.-Y.; Chen Y.-C.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tsai W.; SHAN-CHWEN CHANG; Tien H.-F.; Luh K.-T. |
| 臺大學術典藏 |
2020-12-30T02:44:12Z |
2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan
|
Ko B.-S.;Chen W.-T.;Kung H.-C.;Wu U.-I.;Tang J.-L.;Yao M.;Chen Y.-C.;Tien H.-F.;Shan-Chwen Chang;Chuang Y.-C.;Lin D.-T.;The Infectious Diseases Society Of Taiwan, The Hematology Society Of Taiwan, The Taiwan Society Of Blood;Marrow Transplantation, Medical Foundation In Memory Of Dr Deh-Lin Cheng, Foundation Of Professor Wei-Chuan Hsieh For Infectious Diseases Research;Education, Cy Lee'S Research Foundation For Pediatric Infectious Diseases;Vaccines; Ko B.-S.; Chen W.-T.; Kung H.-C.; Wu U.-I.; Tang J.-L.; Yao M.; Chen Y.-C.; Tien H.-F.; SHAN-CHWEN CHANG; Chuang Y.-C.; Lin D.-T.; The Infectious Diseases Society of Taiwan, The Hematology Society of Taiwan, The Taiwan Society of Blood; Marrow Transplantation, Medical Foundation in Memory of Dr Deh-Lin Cheng, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research; Education, CY Lee's Research Foundation for Pediatric Infectious Diseases; Vaccines |
| 臺大學術典藏 |
2020-12-30T02:44:00Z |
Prior invasive fungal infection is not a contraindication for subsequent allogeneic bone marrow transplantation in adult patients with hematologic malignancies [4]
|
SHAN-CHWEN CHANG; Hung C.-C.; Tang J.-L.; Yao M.; Wang J.-T.; Wang J.-T.;Yao M.;Tang J.-L.;Shan-Chwen Chang;Hung C.-C. |
| 臺大學術典藏 |
2020-12-29T03:31:10Z |
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
|
Yao M.; Chou W.-C.; Huang S.-Y.; ARISTINE CHENG; Tien F.-M.; Chen C.-Y.;Tien F.-M.;Aristine Cheng;Huang S.-Y.;Chou W.-C.;Yao M.;Tang J.-L.;Tien H.-F.;Sheng W.-H.; Chen C.-Y.; Tang J.-L.; Tien H.-F.; Sheng W.-H. |
| 臺大學術典藏 |
2020-12-29T03:09:10Z |
Prior invasive fungal infection is not a contraindication for subsequent allogeneic bone marrow transplantation in adult patients with hematologic malignancies [4]
|
Jann-Tay Wang;Yao M.;Tang J.-L.;Chang S.-C.;Hung C.-C.; JANN-TAY WANG; Yao M.; Tang J.-L.; Chang S.-C.; Hung C.-C. |
| 臺大學術典藏 |
2020-12-24T08:57:00Z |
2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan
|
Ko B.-S.;Chen W.-T.;Kung H.-C.;Un-In Wu;Tang J.-L.;Yao M.;Chen Y.-C.;Tien H.-F.;Chang S.-C.;Chuang Y.-C.;Lin D.-T.;The Infectious Diseases Society Of Taiwan, The Hematology Society Of Taiwan, The Taiwan Society Of Blood;Marrow Transplantation, Medical Foundation In Memory Of Dr Deh-Lin Cheng, Foundation Of Professor Wei-Chuan Hsieh For Infectious Diseases Research;Education, Cy Lee'S Research Foundation For Pediatric Infectious Diseases;Vaccines; Ko B.-S.; Vaccines; Education, CY Lee's Research Foundation for Pediatric Infectious Diseases; Marrow Transplantation, Medical Foundation in Memory of Dr Deh-Lin Cheng, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research; The Infectious Diseases Society of Taiwan, The Hematology Society of Taiwan, The Taiwan Society of Blood; Lin D.-T.; Chen W.-T.; Kung H.-C.; UN-IN WU; Tang J.-L.; Yao M.; Chen Y.-C.; Tien H.-F.; Chang S.-C.; Chuang Y.-C. |
| 臺大學術典藏 |
2020-12-23T06:26:35Z |
Pleural effusion heralds acute leukemic transformation of chronic myelomonocytic leukemia
|
Huang C.-T.; PING-HUNG KUO; Yao M.; Tsai Y.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-18T08:39:41Z |
Prophylactic use of moxifloxacin in patients receiving bone marrow transplants was not associated with increased ciprofloxacin resistance in Escherichia coli and enterococci [5]
|
Po-Ren Hsueh;Cheng H.-J.;Tang J.-L.;Yao M.;Tien H.-F.; PO-REN HSUEH; Cheng H.-J.; Tang J.-L.; Yao M.; Tien H.-F. |
| 臺大學術典藏 |
2020-12-18T08:38:16Z |
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: A case report and literature review
|
Chen Y.-C.; Kuo Y.-M.; Hsiao C.-H.; PO-REN HSUEH; Yao M.; Ko B.-S.; Chen W.-T.; Liu J.-Y.;Chen W.-T.;Ko B.-S.;Yao M.;Po-Ren Hsueh;Hsiao C.-H.;Kuo Y.-M.;Chen Y.-C.; Liu J.-Y. |
| 臺大學術典藏 |
2020-12-18T08:37:48Z |
Clinical features of patients with infections caused by candida guilliermondii and candida fermentati and antifungal susceptibility of the isolates at a medical centre in taiwan, 2001-10
|
Chen C.-Y.;Huang S.-Y.;Tang J.-L.;Tsay W.;Yao M.;Ko B.-S.;Chou W.-C.;Tien H.-F.;Po-Ren Hsueh; PO-REN HSUEH; Chen C.-Y.; Huang S.-Y.; Tang J.-L.; Tsay W.; Yao M.; Ko B.-S.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2020-12-18T08:37:36Z |
Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12
|
Chen C.-Y.; Sheng W.-H.; Huang S.-Y.; Chou W.-C.; Yao M.; Tang J.-L.; Tsay W.; Tien H.-F.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:37:16Z |
Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008–2013
|
Chen C.-Y.;Tien F.-M.;Sheng W.-H.;Huang S.-Y.;Yao M.;Tang J.-L.;Tsay W.;Tien H.-F.;Po-Ren Hsueh; Chen C.-Y.; Tien F.-M.; Sheng W.-H.; Huang S.-Y.; Yao M.; Tang J.-L.; Tsay W.; Tien H.-F.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:37:05Z |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Ko B.-S.; Li C.-C.; Hsu C.-A.; Tang J.-L.; Tien H.-F.; Yao M.; Wu S.-J.; PO-REN HSUEH; Lin C.-T.; Lin C.-T.;Po-Ren Hsueh;Wu S.-J.;Yao M.;Ko B.-S.;Li C.-C.;Hsu C.-A.;Tang J.-L.;Tien H.-F. |
| 臺大學術典藏 |
2020-12-18T05:28:50Z |
Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome [1]
|
Yeh Y.-C.; Huang C.-F.; Chiou R.-J.; Yao M.; Ko B.-S.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Tien H.-F.; HSIU-HAO CHANG; Tsay W.; Tang J.-L.; Lin L.-I.; Chen C.-Y.; Chen C.-Y.;Lin L.-I.;Tang J.-L.;Tsay W.;Hsiu-Hao Chang;Yeh Y.-C.;Huang C.-F.;Chiou R.-J.;Yao M.;Ko B.-S.;Chen Y.-C.;Lin K.-H.;Lin D.-T.;Tien H.-F. |
| 臺大學術典藏 |
2020-12-18T05:28:48Z |
Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute
|
Hou H.-A.; Yao M.; Tang J.-L.; Chen Y.-K.; Ko B.-S.; Huang S.-Y.; Tien H.-F.; HSIU-HAO CHANG; Lu M.-Y.; Lin T.-T.; Lin K.-H.; Hsiao C.-H.; Lin C.-W.; Chen Y.-C. |
| 臺大學術典藏 |
2020-12-16T08:52:13Z |
The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan
|
Chien-Chang Lee;Chang H.-H.;Lu M.-Y.;Yang Y.-L.;Chou S.-W.;Lin D.-T.;Jou S.-T.;Yao M.;Li C.-C.;Yeh S.-P.;Chen M.-H.;Gau J.-P.;Li S.-S.;Wang P.-N.;Liu Y.-C.;Wang T.-F.;Tan T.-D.;Lee M.-Y.;Yu M.-S.;Wang C.-C.;Lin S.-C.;Chen Y.-C.;Su Y.-C.;Su K.-Y.;Lin K.-H.; CHIEN-CHANG LEE; Chang H.-H.; Lu M.-Y.; Yang Y.-L.; Chou S.-W.; Lin D.-T.; Jou S.-T.; Yao M.; Li C.-C.; Yeh S.-P.; Chen M.-H.; Gau J.-P.; Li S.-S.; Wang P.-N.; Liu Y.-C.; Wang T.-F.; Tan T.-D.; Lee M.-Y.; Yu M.-S.; Wang C.-C.; Lin S.-C.; Chen Y.-C.; Su Y.-C.; Su K.-Y.; Lin K.-H. |
| 臺大學術典藏 |
2020-12-16T07:22:01Z |
Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute
|
Hou H.-A.; Yao M.; Tang J.-L.; Chen Y.-K.; Ko B.-S.; Huang S.-Y.; Tien H.-F.; Chang H.-H.; MENG-YAO LU; Lin T.-T.; Lin K.-H.; Hsiao C.-H.; Lin C.-W.; Chen Y.-C. |
